These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


200 related items for PubMed ID: 29417580

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.
    Zhang J, Zhuang DX, Yao CJ, Lin CP, Wang TL, Qin ZY, Wu JS.
    J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vivo imaging of glucose consumption and lactate concentration in human gliomas.
    Herholz K, Heindel W, Luyten PR, denHollander JA, Pietrzyk U, Voges J, Kugel H, Friedmann G, Heiss WD.
    Ann Neurol; 1992 Mar; 31(3):319-27. PubMed ID: 1637139
    [Abstract] [Full Text] [Related]

  • 5. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA, Henze M, Tüttenberg J, Stieltjes B, Meissner M, Zimmer F, Burkholder I, Kroll A, Combs SE, Vogt-Schaden M, Giesel FL, Zoubaa S, Haberkorn U, Kauczor HU, Essig M.
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Metabolic and transcriptomic profiles of glioblastoma invasion revealed by comparisons between patients and corresponding orthotopic xenografts in mice.
    Cudalbu C, Bady P, Lai M, Xin L, Gusyatiner O, Hamou MF, Lepore M, Brouland JP, Daniel RT, Hottinger AF, Hegi ME.
    Acta Neuropathol Commun; 2021 Aug 04; 9(1):133. PubMed ID: 34348785
    [Abstract] [Full Text] [Related]

  • 9. MR-detectable metabolic biomarkers of response to mutant IDH inhibition in low-grade glioma.
    Molloy AR, Najac C, Viswanath P, Lakhani A, Subramani E, Batsios G, Radoul M, Gillespie AM, Pieper RO, Ronen SM.
    Theranostics; 2020 Aug 04; 10(19):8757-8770. PubMed ID: 32754276
    [Abstract] [Full Text] [Related]

  • 10. [1-(13)C]glucose metabolism in the tumoral and nontumoral cerebral tissue of a glioma-bearing rat.
    Bouzier AK, Quesson B, Valeins H, Canioni P, Merle M.
    J Neurochem; 1999 Jun 04; 72(6):2445-55. PubMed ID: 10349854
    [Abstract] [Full Text] [Related]

  • 11. A novel, integrated PET-guided MRS technique resulting in more accurate initial diagnosis of high-grade glioma.
    Kim ES, Satter M, Reed M, Fadell R, Kardan A.
    Neuroradiol J; 2016 Jun 04; 29(3):193-7. PubMed ID: 27122050
    [Abstract] [Full Text] [Related]

  • 12. Multimodality In Vivo Imaging of Perfusion and Glycolysis in a Rat Model of C6 Glioma.
    Qi Q, Fox MS, Lim H, Bartha R, Scholl TJ, Hoffman L, Lee TY, Thiessen JD.
    Mol Imaging Biol; 2021 Aug 04; 23(4):516-526. PubMed ID: 33534038
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
    Wang HE, Wu SY, Chang CW, Liu RS, Hwang LC, Lee TW, Chen JC, Hwang JJ.
    Nucl Med Biol; 2005 May 04; 32(4):367-75. PubMed ID: 15878506
    [Abstract] [Full Text] [Related]

  • 14. In vivo 13C MRS in the mouse brain at 14.1 Tesla and metabolic flux quantification under infusion of [1,6-13C2]glucose.
    Lai M, Lanz B, Poitry-Yamate C, Romero JF, Berset CM, Cudalbu C, Gruetter R.
    J Cereb Blood Flow Metab; 2018 Oct 04; 38(10):1701-1714. PubMed ID: 29047296
    [Abstract] [Full Text] [Related]

  • 15. Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors: 1H-MRS study.
    Artzi M, Liberman G, Vaisman N, Bokstein F, Vitinshtein F, Aizenstein O, Ben Bashat D.
    J Neurooncol; 2017 Apr 04; 132(2):267-275. PubMed ID: 28074323
    [Abstract] [Full Text] [Related]

  • 16. 1H magnetic resonance spectroscopy of 2H-to-1H exchange quantifies the dynamics of cellular metabolism in vivo.
    Rich LJ, Bagga P, Wilson NE, Schnall MD, Detre JA, Haris M, Reddy R.
    Nat Biomed Eng; 2020 Mar 04; 4(3):335-342. PubMed ID: 31988460
    [Abstract] [Full Text] [Related]

  • 17. Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas.
    Prat R, Galeano I, Lucas A, Martínez JC, Martín M, Amador R, Reynés G.
    J Clin Neurosci; 2010 Jan 04; 17(1):50-3. PubMed ID: 19959364
    [Abstract] [Full Text] [Related]

  • 18. Comparison of magnetic resonance spectroscopy and positron emission tomography in detection of tumor recurrence in posttreatment of glioma: A diagnostic meta-analysis.
    Wang X, Hu X, Xie P, Li W, Li X, Ma L.
    Asia Pac J Clin Oncol; 2015 Jun 04; 11(2):97-105. PubMed ID: 24783970
    [Abstract] [Full Text] [Related]

  • 19. Glutamate metabolism in temporal lobe epilepsy as revealed by dynamic proton MRS following the infusion of [U13-C] glucose.
    Bartnik-Olson BL, Ding D, Howe J, Shah A, Losey T.
    Epilepsy Res; 2017 Oct 04; 136():46-53. PubMed ID: 28763722
    [Abstract] [Full Text] [Related]

  • 20. Multimodal elucidation of choline metabolism in a murine glioma model using magnetic resonance spectroscopy and 11C-choline positron emission tomography.
    Wehrl HF, Schwab J, Hasenbach K, Reischl G, Tabatabai G, Quintanilla-Martinez L, Jiru F, Chughtai K, Kiss A, Cay F, Bukala D, Heeren RM, Pichler BJ, Sauter AW.
    Cancer Res; 2013 Mar 01; 73(5):1470-80. PubMed ID: 23345160
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.